SIA
BIIB icon

Sit Investment Associates’s Biogen BIIB Stock Holding History

Sit Investment Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,320
Closed -$1.51M – 518
2016
Q4 		$1.51M Buy
5,320
+450
+9% +$133K 0.04% 292
2016
Q3 		$1.52M Sell
4,870
-150
-3% -$44.4K 0.04% 265
2016
Q2 		$1.21M Sell
5,020
-2,545
-34% -$671K 0.03% 289
2016
Q1 		$1.97M Sell
7,565
-100
-1% -$26.4K 0.04% 250
2015
Q4 		$2.35M Sell
7,665
-200
-3% -$57.5K 0.04% 230
2015
Q3 		$2.29M Buy
+7,865
New +$2.6M 0.04% 233

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sit Investment Associates's BIIB Position: Q1 2017 in Review

Sit Investment Associates sold out of Biogen (BIIB) in Q1 2017, closing a stake of 5,320 shares — an estimated $1.51M sold.

Sit Investment Associates first reported a position in BIIB in Q3 2015 and held it in 6 quarters. The position peaked at $2.35M in Q4 2015. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Sit Investment Associates reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Sit Investment Associates sold 5,320 Biogen shares in Q1 2017, an estimated $1.51M.
  • Sit Investment Associates first reported a position in Biogen in Q3 2015 and held it in 6 quarters.
  • Sit Investment Associates's Biogen position peaked at $2.35M in Q4 2015.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Sit Investment Associates's 13F filing for Q1 2017, filed 25 Apr 2017.